The biochemical mechanisms by which activated platelets participate in exposing receptors for the assembly of enzyme-cofactor-substrate complexes at all stages of the blood coagulation cascade are reviewed. Information derived from studies conducted during the last 30 years supports the concept that the initiation of blood coagulation is triggered by exposure of tissue factor at injury sites, leading to the generation of minute quantities of thrombin (limited by tissue factor pathway inhibitor), sufficient to activate platelets, factors XI, VIII, and V, and trigger the consolidation pathway (i.e., the sequential activation of factors XI, IX, X, and prothrombin on the activated platelet surface), leading to the generation of sufficient thrombin to convert fibrinogen to fibrin and effect hemostasis. Platelets localize coagulation to the hemostatic thrombus and protect coagulation enzymes from inhibition by both plasma and platelet inhibitors (e.g., protease nexin 2), thus preventing disseminated intravascular coagulation.
KEYWORDS
Consolidation pathway of coagulation - tissue factor pathway of coagulation - platelet receptors for coagulation proteins
REFERENCES
1 Walsh P N, Factor X I. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 191-202
2
Walsh P N.
Platelet coagulant activities and hemostasis: a hypothesis.
Blood.
1974;
43
597-605
3 Tracy P B. Role of platelets and leukocytes in coagulation. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 575-596
4
Ahmad S S, London F S, Walsh P N.
The assembly of the factor X-activating complex on activated human platelets.
J Thromb Haemost.
2003;
1
48-59
5
Baglia F A, Walsh P N.
Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
Biochemistry.
1998;
37
2271-2281
6
Baglia F A, Walsh P N.
Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
J Biol Chem.
2000;
275
20514-20519
7
Gailani D, Broze Jr G J.
Factor XI activation in a revised model of blood coagulation.
Science.
1991;
253
909-912
8 Morrissey J H. Tissue factor and factor VII initiation of coagulation. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 89-102
9
Naito K, Fujikawa K.
Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces.
J Biol Chem.
1991;
266
7353-7358
10
MacFarlane R G.
An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier.
Nature.
1964;
202
498-499
11
Davie E W, Ratnoff O D.
Waterfall sequence for intrinsic blood clotting.
Science.
1964;
145
1310-1312
12 Bock S C. Antithrombin III and heparin cofactor II. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 321-365
13 Esmon C T, Protein C. Protein S, and thrombomodulin. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 335-353
14 Pizzo S V, Wu S M. Alpha-macroglobulins and kunins. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 367-379
15
Walsh P N.
Roles of factor XI, platelets and tissue factor-initiated blood coagulation.
J Thromb Haemost.
2003;
1
2081-2086
16 Colman R W. Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 103-122
17
Walsh P N.
The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII.
Br J Haematol.
1972;
22
393-405
18
Walsh P N.
Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities.
Br J Haematol.
1972;
22
205-217
19
Walsh P N.
The role of platelets in the contact phase of blood coagulation.
Br J Haematol.
1972;
22
237-254
20
Walsh P N.
The effect of dilution of plasma on coagulation. The significance of the dilution-activation phenomenon for the study of platelet coagulant activities.
Br J Haematol.
1972;
22
219-236
21
Walsh P N, Biggs R.
The role of platelets in intrinsic factor-Xa formation.
Br J Haematol.
1972;
22
743-760
22 Kaufman R J, Antonarakis S E, Fay P J. Factor VIII and hemophilia A. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 135-156
23 Thompson A R. Molecular biology of factor IX. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 4th ed. Philadelphia; Lippincott Williams & Wilkins 2001: 123-134
24
Asakai R, Chung D W, Davie E W, Seligsohn U.
Factor XI deficiency in Ashkenazi Jews in Israel.
N Engl J Med.
1991;
325
153-158
25
Bolton-Maggs P H, Young Wan-Yin B, McCraw A H, Slack J, Kernoff P B.
Inheritance and bleeding in factor XI deficiency.
Br J Haematol.
1988;
69
521-528
26
Hu C J, Baglia F A, Mills D C, Konkle B A, Walsh P N.
Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression.
Blood.
1998;
91
3800-3807
27
Leiba H, Ramot B, Many A.
Hereditary and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency.
Br J Haematol.
1965;
11
654-665
28
Ragni M V, Sinha D, Seaman F, Lewis J H, Spero J A, Walsh P N.
Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds.
Blood.
1985;
65
719-724
29
Rapaport S I, Proctor R R, Patch M J, Yettra M.
The mode of inheritance of PTA deficiency: evidence for the existence of a major PTA deficiency and a minor PTA deficiency.
Blood.
1961;
18
149-155
30
Rosenthal R L, Dreskin O H, Rosenthal N.
New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.
Proc Soc Exp Biol Med.
1953;
82
171-174
31
Sidi A, Seligsohn U, Jonas P, Many M.
Factor XI deficiency: detection and management during urologic surgery.
J Urol.
1978;
119
528-530
32
Anson D S, Choo K H, Rees D J et al..
The gene structure of human anti-haemophilic factor IX.
EMBO J.
1984;
3
1053-1060
33
Di Scipio R G, Kurachi K, Davie E W.
Activation of human factor IX (Christmas factor).
J Clin Invest.
1978;
61
1528-1538
34
Fujikawa K, Legaz M E, Kato H, Davie E W.
The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).
Biochemistry.
1974;
13
4508-4516
35
Jagadeeswaran P, Lavelle D E, Kaul R, Mohandas T, Warren S T.
Isolation and characterization of human factor IX cDNA: identification of Taq I polymorphism and regional assignment.
Somat Cell Mol Genet.
1984;
10
465-473
36
Jaye M, de la Salle H, Schamber F et al..
Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX.
Nucleic Acids Res.
1983;
11
2325-2335
37
Kurachi K, Davie E W.
Isolation and characterization of a cDNA coding for human factor IX.
Proc Natl Acad Sci USA.
1982;
79
6461-6464
38
Osterud B, Bouma B N, Griffin J H.
Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI.
J Biol Chem.
1978;
253
5946-5951
39
Sinha D, Seaman F S, Walsh P N.
Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.
Biochemistry.
1987;
26
3768-3775
40
Yoshitake S, Schach B G, Foster D C, Davie E W, Kurachi K.
Nucleotide sequence of the gene for human factor IX (antihemophilic factor B).
Biochemistry.
1985;
24
3736-3750
41
Osterud B, Rapaport S I.
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
Proc Natl Acad Sci USA.
1977;
74
5260-5264
42
Baglia F A, Badellino K O, Li C Q, Lopez J A, Walsh P N.
Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.
J Biol Chem.
2002;
277
1662-1668
43
Baglia F A, Shrimpton C N, Lopez J A, Walsh P N.
The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane.
J Biol Chem.
2003;
278
21744-21750
44
Broze G JJ, Miletich J P.
Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.
Proc Natl Acad Sci USA.
1987;
84
1886-1890
45
Broze G JJ, Miletich J P.
Characterization of the inhibition of tissue factor in serum.
Blood.
1987;
69
150-155
46
Hubbard A R, Jennings C A.
Inhibition of tissue thromboplastin-mediated blood coagulation.
Thromb Res.
1986;
42
489-498
47
Hubbard A R, Jennings C A.
Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
Thromb Res.
1987;
46
527-537
48
Morrison S A, Jesty J.
Tissue factor-dependent activation of tritium labeled factor IX and factor X in human plasma.
Blood.
1984;
63
1338-1347
49
Rao L VM, Rapaport S I.
Studies on the mechanisms of inactivation of the extrinsic pathway of coagulation.
Blood.
1987;
69
645-651
50
Sanders N L, Bajaj S P, Zivelin A, Rapaport S I.
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
Blood.
1985;
66
204-212
51
Baglia F A, Jameson B A, Walsh P N.
Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI.
J Biol Chem.
1995;
270
6734-6740
52
Greengard J S, Heeb M J, Ersdal E, Walsh P N, Griffin J H.
Binding of coagulation factor XI to washed human platelets.
Biochemistry.
1986;
25
3884-3890
53
Ho D H, Baglia F A, Walsh P N.
Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the Apple 3 domain.
Biochemistry.
2000;
39
316-323
54
Biggs R, Denson K W, Riesenberg D, McIntyre C.
The coagulant activity of platelets.
Br J Haematol.
1968;
15
283-296
55
Baglia F A, Seaman F S, Walsh P N.
The Apple 1 and apple 4 domains of factor XI act synergistically to promote the surface-mediated activation of factor XI by factor XIIa.
Blood.
1995;
85
2078-2083
56
Ho D H, Badellino K, Baglia F A et al..
The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface.
J Biol Chem.
2000;
275
25139-25145
57
Sun M F, Baglia F A, Ho D et al..
Defective binding of factor XI-N248 to activated human platelets.
Blood.
2001;
98
125-129
58
Baird T R, Walsh P N.
The interaction of factor XIa with activated platelets but not endothelial cells promotes the activation of factor IX in the consolidation phase of blood coagulation.
J Biol Chem.
2002;
277
38462-38467
59
Gailani D, Ho D, Sun M F, Cheng Q, Walsh P N.
Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.
Blood.
2001;
97
3117-3122
60
Sinha D, Seaman F S, Koshy A, Knight L C, Walsh P N.
Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
J Clin Invest.
1984;
73
1550-1556
61
Ahmad S S, London F S, Walsh P N.
Binding studies of the enzyme (factor IXa) with the cofactor (factor VIII) in the assembly of factor-X activating complex on the activated platelet surface.
J Thromb Haemost.
2003;
1
2348-2355
62
Ahmad S S, Rawala-Sheikh R, Walsh P N.
Comparative interactions of factor IX and factor IXa with human platelets.
J Biol Chem.
1989;
264
3244-3251
63
Ahmad S S, Rawala-Sheikh R, Walsh P N.
Platelet receptor occupancy with factor IXa promotes factor X activation.
J Biol Chem.
1989;
264
20012-20016
64
Ahmad S S, Wong M Y, Rawala R, Jameson B A, Walsh P N.
Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Biochemistry.
1998;
37
1671-1679
65
London F S, Walsh P N.
Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
Biochemistry.
2000;
39
9850-9858
66
Ahmad S S, Rawala R, Cheung W F, Stafford D W, Walsh P N.
The role of the second growth-factor domain of human factor IXa in binding to platelets and in factor-X activation.
Biochem J.
1995;
310
427-431
67
Ahmad S S, Rawala-Sheikh R, Ashby B, Walsh P N.
Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.
J Clin Invest.
1989;
84
824-828
68
Ahmad S S, Rawala-Sheikh R, Cheung W F, Jameson B A, Stafford D W, Walsh P N.
High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.
Biochemistry.
1994;
33
12048-12055
69
Ahmad S S, Rawala-Sheikh R, Cheung W F, Stafford D W, Walsh P N.
The role of the first growth factor domain of human factor IXa in binding to platelets and in factor X activation.
J Biol Chem.
1992;
267
8571-8576
70
Ahmad S S, Rawala-Sheikh R, Monroe D M, Roberts H R, Walsh P N.
Comparative platelet binding and kinetic studies with normal and variant factor IXa molecules.
J Biol Chem.
1990;
265
20907-20911
71
Rawala-Sheikh R, Ahmad S S, Ashby B, Walsh P N.
Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Biochemistry.
1990;
29
2606-2611
72
Rawala-Sheikh R, Ahmad S S, Monroe D M, Roberts H R, Walsh P N.
Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activation.
Blood.
1992;
79
398-405
73
Wilkinson F H, Ahmad S S, Walsh P N.
The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
J Biol Chem.
2002;
277
5734-5741
74
Wilkinson F H, London F S, Walsh P N.
Residues 88-109 of factor IXa are important for assembly of the factor-X activating complex.
J Biol Chem.
2002;
277
5725-5733
75
Ahmad S S, Scandura J M, Walsh P N.
Structural and functional characterization of platelet receptor-mediated factor VIII binding.
J Biol Chem.
2000;
275
13071-13081
76
Ahmad S S, Walsh P N.
Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Biochemistry.
2002;
41
11269-11276
77
Scandura J M, Ahmad S S, Walsh P N.
A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
Biochemistry.
1996;
35
8890-8902
78
Scandura J M, Walsh P N.
Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa.
Biochemistry.
1996;
35
8903-8913
79
Dahlback B, Stenflo J.
Binding of bovine coagulation factor Xa to platelets.
Biochemistry.
1978;
17
4938-4945
80
Kane W H, Majerus P W.
The interaction of human coagulation factor Va with platelets.
J Biol Chem.
1982;
257
3963-3969
81
Miletich J P, Jackson C M, Majerus P W.
Interaction of coagulation factor Xa with human platelets.
Proc Natl Acad Sci USA.
1977;
74
4033-4036
82
Miletich J P, Jackson C M, Majerus P W.
Properties of the factor Xa binding site on human platelets.
J Biol Chem.
1978;
253
6908-6916
83
Miletich J P, Kane W H, Hofmann S L, Stanford N, Majerus P W.
Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder.
Blood.
1979;
54
1015-1022
84
Miletich J P, Majerus D W, Majerus P W.
Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
J Clin Invest.
1978;
62
824-831
85
Tracy P B, Eide L L, Mann K G.
Human prothrombinase complex assembly and function on isolated peripheral blood cell populations.
J Biol Chem.
1985;
260
2119-2124
86
Tracy P B, Nesheim M E, Mann K G.
Coordinate binding of factor Va and factor Xa to the unstimulated platelet.
J Biol Chem.
1981;
256
743-751
87
Tracy P B, Nesheim M E, Mann K G.
Platelet factor Xa receptor.
Methods Enzymol.
1992;
215
329-360
88
Tracy P B, Peterson J M, Nesheim M E, McDuffie F C, Mann K G.
Interaction of coagulation factor V and factor Va with platelets.
J Biol Chem.
1979;
254
10354-10361
89
Tracy P B, Mann K G.
Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.
Proc Natl Acad Sci USA.
1983;
80
2380-2384
90
Tracy P B, Nesheim M E, Mann K G.
Proteolytic alterations of factor Va bound to platelets.
J Biol Chem.
1983;
258
662-669
91
Bouchard B A, Catcher C S, Thrash B R, Adida C, Tracy P B.
Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation.
J Biol Chem.
1997;
272
9244-9251
92 Walsh P N. Platelet-coagulant protein interactions. In: Colman RW, Hirsh J, Marder VJ, Salzman EW Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia; JB Lippincott Company 1994: 629-651
93
Walsh P N, Griffin J H.
Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
Blood.
1981;
57
106-118
94
Berman C L, Yeo E L, Wencel-Drake J D, Furie B C, Ginsberg M H, Furie B.
A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein.
J Clin Invest.
1986;
78
130-137
95
Conde I, Shrimpton C N, Thiagarajan P, Lopez J A.
Tissue factor-bearing microparticles arise from monocyte lipid rafts and can fuse with activated platelets, consolidating all of the membrane-bound coagulation reactions on the platelet surface.
J Thromb Haemost.
2003;
I
146 (Abstr)
96
Falati S, Gross P, Merrill-Skoloff G, Furie B C, Furie B.
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.
Nat Med.
2002;
8
1175-1181
97
Giesen P L, Rauch U, Bohrmann B et al..
Blood-borne tissue factor: another view of thrombosis.
Proc Natl Acad Sci USA.
1999;
96
2311-2315
98
Himber J, Kling D, Fallon J T, Nemerson Y, Riederer M A.
In situ localization of tissue factor in human thrombi.
Blood.
2002;
99
4249-4250
99
Morrissey J H.
Tissue factor: in at the start... and the finish?.
J Thromb Haemost.
2003;
1
878-880
100
Rauch U, Bonderman D, Bohrmann B et al..
Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor.
Blood.
2000;
96
170-175
101
Rauch U, Nemerson Y.
Tissue factor, the blood, and the arterial wall.
Trends Cardiovasc Med.
2000;
10
139-143
102
Walsh P N.
Roles of platelets and factor XI in the initiation of blood coagulation by thrombin.
Thromb Haemost.
2001;
86
75-82
103
Baglia F A, Badellino K O, Ho D H, Dasari V R, Walsh P N.
A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XI.
J Biol Chem.
2000;
275
31954-31962
104
Baglia F A, Walsh P N.
A binding site for thrombin in the apple 1 domain of factor XI.
J Biol Chem.
1996;
271
3652-3658
105
Baird T R, Walsh P N.
Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation.
J Biol Chem.
2002;
277
28498-28503
106
Walsh P N, Sinha D, Koshy A, Seaman F S, Bradford H.
Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
Blood.
1986;
68
225-230
107
Walsh P N, Sinha D, Kueppers F, Seaman F S, Blankstein K B.
Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
J Clin Invest.
1987;
80
1578-1586
108
Bush A I, Martins R N, Rumble B et al..
The amyloid precursor protein of Alzheimer’s disease is released by human platelets.
J Biol Chem.
1990;
265
15977-15983
109
Scandura J M, Zhang Y, Van Nostrand W E, Walsh P N.
Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
Biochemistry.
1997;
36
412-420
110
Smith R P, Higuchi D A, Broze Jr G J.
Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein.
Science.
1990;
248
1126-1128
111
Van Nostrand W E, Schmaier A H, Farrow J S, Cunningham D D.
Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein.
Science.
1990;
248
745-748
112
Zhang Y, Scandura J M, Van Nostrand W E, Walsh P N.
The mechanism by which heparin promotes the inhibition of coagulation factor XIa by protease nexin-2.
J Biol Chem.
1997;
272
26139-26144
113
Komiyama Y, Nomura S, Murakami T et al..
Purification and characterization of platelet-type factor XI from human platelets.
Thromb Haemost.
1993;
69
1238 (Abstr)
114
Lipscomb M S, Walsh P N.
Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.
J Clin Invest.
1979;
63
1006-1014
115
Schiffman S, Rapaport S I, Chong M M.
Platelets and initiation of intrinsic clotting.
Br J Haematol.
1973;
24
633-642
116
Schiffman S, Yeh C H.
Purification and characterization of platelet factor XI.
Thromb Res.
1990;
60
87-97
117
Tuszynski G P, Bevacqua S J, Schmaier A H, Colman R W, Walsh P N.
Factor XI antigen and activity in human platelets.
Blood.
1982;
59
1148-1156
118
Hsu T C, Shore S K, Seshsmma T, Bagasra O, Walsh P N.
Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene.
J Biol Chem.
1998;
273
13787-13793
119
Asakai R, Chung D W, Ratnoff O D, Davie E W.
Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.
Proc Natl Acad Sci USA.
1989;
86
7667-7671
120
Giannelli F, Green P M, Sommer S S et al..
Haemophilia B: database of point mutations and short additions and deletions-eighth edition.
Nucleic Acids Res.
1998;
26
265-268
121
Hancock J F, Wieland K, Pugh R E et al..
A molecular genetic study of factor XI deficiency.
Blood.
1991;
77
1942-1948
122
Martincic D, Zimmerman S A, Ware R E, Sun M F, Whitlock J A, Gailani D.
Identification of mutations and polymorphisms in factor XI genes of an African-American family by dideoxy fingerprinting.
Blood.
1998;
92
3309-3317
123
Meijers J C, Davie E W, Chung D W.
Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency.
Blood.
1992;
79
1435-1440
124
Meijers J C, Mulvihill E R, Davie E W, Chung D W.
Apple four in human blood coagulation factor XI mediates dimer formation.
Biochemistry.
1992;
31
4680-4684
125
Peretz H, Zivelin A, Usher S, Seligsohn U.
A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency.
Hum Mutat.
1996;
8
77-78
126
Pugh R E, McVey J H, Tuddenham E G, Hancock J F.
Six point mutations that cause factor XI deficiency.
Blood.
1995;
85
1509-1516
127
Seligsohn U, Weiss E, Kulka T, Eichel R, Zwang E, Pereta H.
The frequency of the type II and type III mutations causing factor XI deficiency in the general Jewish population.
Thromb Haemost.
1993;
69
1296 (Abstr)
128
Shirk R A, Konkle B A, Walsh P N.
Nonsense mutation in exon V of the factor XI gene does not abolish platelet factor XI expression.
Br J Haematol.
2000;
111
91-95
129
Wistinghausen B, Reischer A, Oddoux C, Ostrer H, Nardi M, Karpatkin M.
Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11.
Br J Haematol.
1997;
99
575-577
130
Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U.
Dental surgery in patients with severe factor XI deficiency without plasma replacement.
Blood Coagul Fibrinolysis.
1992;
3
465-468
131
Gailani D.
Advances and dilemmas in factor XI.
Curr Opin Hematol.
1994;
1
347-353
132
Kitchens C S.
Factor XI: a review of its biochemistry and deficiency.
Semin Thromb Hemost.
1991;
17
55-72
133
Seligsohn U.
Factor XI deficiency.
Thromb Haemost.
1993;
70
68-71
134
Martincic D, Kravtsov V, Gailani D.
Factor XI messenger RNA in human platelets.
Blood.
1999;
94
3397-3404
135
Wong M Y, Gurr J A, Walsh P N.
The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
Biochemistry.
1999;
38
8948-8960
136
Nesheim M E, Pittman D D, Wang J H, Slonosky D, Giles A R, Kaufman R J.
The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets.
J Biol Chem.
1988;
263
16467-16470
137
Foster P A, Fulcher C A, Houghten R A, Zimmerman T S.
Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.
Blood.
1990;
75
1999-2004
138
Saenko E L, Scandella D.
A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
J Biol Chem.
1995;
270
13826-13833
139
Pratt K P, Shen B W, Takeshima K, Davie E W, Fujikawa K, Stoddard B L.
Structure of the C2 domain of human factor VIII at 1.5 A resolution.
Nature.
1999;
402
439-442
140
Ahmad S S, Walsh P N.
Lipid raft association of the factor VIII C2 domain mediates platelet membrane assembly of factor VIIIa into the factor-X-activating complex.
Blood.
2002;
100
126A
141
Mann K G, Jenny R J, Krishnaswamy S.
Cofactor proteins in the assembly and expression of blood clotting enzyme complexes.
Annu Rev Biochem.
1988;
57
915-956
142
Mann K G, Nesheim M E, Church W R, Haley P, Krishnaswamy S.
Surface-dependent reactions of the vitamin K-dependent enzyme complexes.
Blood.
1990;
76
1-16
143
Kane W H, Lindhout M J, Jackson C M, Majerus P W.
Factor Va-dependent binding of factor Xa to human platelets.
J Biol Chem.
1980;
255
1170-1174
144
Comp P C, Esmon C T.
Activated protein C inhibits platelet prothrombin-converting activity.
Blood.
1979;
54
1272-1281
145
Dahlback B, Stenflo J.
Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa.
Eur J Biochem.
1980;
107
331-335
146
Tracy P B, Eide L L, Bowie E J, Mann K G.
Radioimmunoassay of factor V in human plasma and platelets.
Blood.
1982;
60
59-63
147
Sims P J, Faioni E M, Wiedmer T, Shattil S J.
Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.
J Biol Chem.
1988;
263
18205-18212
148
Sims P J, Rollins S A, Wiedmer T.
Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex.
J Biol Chem.
1989;
264
19228-19235
149
Sims P J, Wiedmer T, Esmon C T, Weiss H J, Shattil S J.
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity.
J Biol Chem.
1989;
264
17049-17057
150
Tans G, Rosing J, Thomassen M C, Heeb M J, Zwaal R F, Griffin J H.
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
Blood.
1991;
77
2641-2648
151
Thiagarajan P, Tait J F.
Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.
J Biol Chem.
1991;
266
24302-24307
152
Weiss H J, Lages B.
Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity-a comparison with Scott syndrome.
Blood.
1997;
89
1599-1611
Professor Peter N WalshM.D. Ph.D.
Sol Sherry Thrombosis Research Center, Temple University School of Medicine
3400 North Broad Street
Philadelphia, PA 19140
eMail: pnw@temple.edu